4//SEC Filing
Shearman Mark S 4
Accession 0001179110-21-006778
CIK 0001650664other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:19 PM ET
Size
7.1 KB
Accession
0001179110-21-006778
Insider Transaction Report
Form 4
Shearman Mark S
EVP, Chief Scientific Officer
Transactions
- Award
Common Stock
2021-06-14+32,701→ 32,701 total - Award
Stock Option (right to buy)
2021-06-14+52,718→ 52,718 totalExercise: $38.53Exp: 2031-06-13→ Common Stock (52,718 underlying)
Footnotes (2)
- [F1]The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on June 14, 2022 continuing through June 14, 2025.
- [F2]This option was granted on June 14, 2021 and is scheduled to vest over four years, with 25% of the shares to vest on June 14, 2022 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through June 14, 2025.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001643799
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:19 PM ET
- Size
- 7.1 KB